Medical Imaging News
FDG-PET/CT study suggests change in breast canc...
FDG-PET/CT's aptitude for finding distant metastases in patients with stage III invasive ductal carcinoma has prompted researchers to suggest that the National Comprehensive Cancer Network (NCCN) add histology to its...
FDG-PET/CT study suggests change in breast canc...
FDG-PET/CT's aptitude for finding distant metastases in patients with stage III invasive ductal carcinoma has prompted researchers to suggest that the National Comprehensive Cancer Network (NCCN) add histology to its...
FDG-PET Helps Detect Alzheimer’s Disease
Images of the brain using FDG-PET can accurately detect Alzheimer's disease in patients presenting with primary progressive aphasia or corticobasal syndrome as focal onset dementias, according to a study published...
FDG-PET Helps Detect Alzheimer’s Disease
Images of the brain using FDG-PET can accurately detect Alzheimer's disease in patients presenting with primary progressive aphasia or corticobasal syndrome as focal onset dementias, according to a study published...
ImaginAb highlights [PET] prostate imaging trial
Imaging agent developer ImaginAb is touting interim results from a phase II clinical trial of its IAB2M imaging agent for managing prostate cancer. {read more here}
ImaginAb highlights [PET] prostate imaging trial
Imaging agent developer ImaginAb is touting interim results from a phase II clinical trial of its IAB2M imaging agent for managing prostate cancer. {read more here}
Florbetaben PET Imaging Diagnoses Amyloid Beta ...
A new scan may make it easier for doctors to accurately diagnose Alzheimer’s disease (AD). The results from the Phase III trial of florbetaben F18 injection, known by the trade...
Florbetaben PET Imaging Diagnoses Amyloid Beta ...
A new scan may make it easier for doctors to accurately diagnose Alzheimer’s disease (AD). The results from the Phase III trial of florbetaben F18 injection, known by the trade...
PET/MRI matches PET/CT for recurrent pelvic cancer
PET/MRI can provide high diagnostic performance for restaging gynecological cancer patients compared with FDG-PET/CT, with only slightly longer scan time and "markedly reduced" radiation exposure, according to a German study...
PET/MRI matches PET/CT for recurrent pelvic cancer
PET/MRI can provide high diagnostic performance for restaging gynecological cancer patients compared with FDG-PET/CT, with only slightly longer scan time and "markedly reduced" radiation exposure, according to a German study...
Molecular imaging biomarker [PET] able to detec...
A recent study has highlighted the ability of prostate-specific membrane antigen (PSMA) PET imaging to detect fast-growing primary prostate cancer and could prove significant in the care of patients with...
Molecular imaging biomarker [PET] able to detec...
A recent study has highlighted the ability of prostate-specific membrane antigen (PSMA) PET imaging to detect fast-growing primary prostate cancer and could prove significant in the care of patients with...